Page last updated: 2024-10-30

labetalol and Infections, Staphylococcal

labetalol has been researched along with Infections, Staphylococcal in 1 studies

Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elsebaei, MM1
Mohammad, H1
Abouf, M1
Abutaleb, NS1
Hegazy, YA1
Ghiaty, A1
Chen, L1
Zhang, J1
Malwal, SR1
Oldfield, E1
Seleem, MN1
Mayhoub, AS1

Other Studies

1 other study available for labetalol and Infections, Staphylococcal

ArticleYear
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
    European journal of medicinal chemistry, 2018, Mar-25, Volume: 148

    Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mic

2018